Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases

被引:0
|
作者
Cui, Ziyou [1 ]
Dewey, Shannamar [1 ,2 ]
Gomes, Aldrin V. [1 ,3 ]
机构
[1] Univ Calif Davis, Dept Neurobiol Physiol & Behav, 176 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA
[2] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Program, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA
来源
关键词
Cardioproteomics; cardiovascular diseases; signaling pathway; proteomics; heart; mass spectrometry; drug signaling;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardioproteomics (Cardiovascular proteomics) is fast becoming an indispensible technique in deciphering changes in signaling pathways that occur in cardiovascular diseases (CVDs). The quality and availability of the instruments and bioinformatics software used for cardioproteomics continues to improve, and these techniques are now available to most cardiovascular researchers either directly or indirectly via university core centers. The heart and aorta are specialized tissues which present unique challenges to investigate. Currently, the diverse range of proteomic techniques available for cardiovascular research makes the choice of the best method or best combination of methods for the disease parameter(s) being investigated as important as the equipment used. This review focuses on proteomic techniques and their applications which have advanced our understanding of the signaling mechanisms involved in CVDs at the levels of protein complex/protein-protein interaction, post-translational modifications and signaling induced protein changes.
引用
收藏
页码:274 / 292
页数:19
相关论文
共 50 条
  • [41] Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases
    Huiying Amelie Zhang
    David D. Kitts
    Molecular and Cellular Biochemistry, 2021, 476 : 3785 - 3814
  • [42] The importance of drug discovery for treatment of cardiovascular diseases FOREWORD
    Kennedy, Charles
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (04) : 355 - 357
  • [43] Cardiovascular diseases since Harvey's discovery.
    Rolleston, H
    LANCET, 1928, 2 : 795 - 801
  • [44] A chemogenomic approach to drug discovery: focus on cardiovascular diseases
    Cases, Montserrat
    Mestres, Jordi
    DRUG DISCOVERY TODAY, 2009, 14 (9-10) : 479 - 485
  • [45] Mechanisms of mitochondrial microRNA regulation in cardiovascular diseases
    Roiz-Valle, David
    Caravia, Xurde M.
    Otin, Carlos Lopez
    MECHANISMS OF AGEING AND DEVELOPMENT, 2023, 212
  • [46] Periodontitis and cardiovascular diseases: The link and relevant mechanisms
    Izumi, Yuichi
    Nagasawa, Toshiyuki
    Umeda, Makoto
    Kobayashi, Hiroaki
    Takeuchi, Yasuo
    Yashiro, Reiko
    Hormdee, Doosadee
    Suda, Tomonari
    Ushida, Yuka
    Wara-aswapati, Nawarat
    JAPANESE DENTAL SCIENCE REVIEW, 2009, 45 (02) : 98 - 108
  • [47] Neural mechanisms of the effect of acupuncture on cardiovascular diseases
    Li, P
    ACUPUNCTURE: IS THERE A PHYSIOLOGICAL BASIS?, 2002, 1238 : 71 - 77
  • [48] Epigenetic mechanisms that underpin metabolic and cardiovascular diseases
    Gluckman, Peter D.
    Hanson, Mark A.
    Buklijas, Tatjana
    Low, Felicia M.
    Beedle, Alan S.
    NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (07) : 401 - 408
  • [49] CARDIOGENE: Deciphering the genetic mechanisms of cardiovascular diseases
    Tania, Sorg
    Ghina, Bou-About
    Marie-France, Champy
    Winfried, Maerz
    Heiko, Runz
    Mohammed, Selloum
    Francois, Spitz
    Amandine, Velt
    Yann, Herault
    TRANSGENIC RESEARCH, 2016, 25 (02) : 263 - 263
  • [50] Epigenetic mechanisms that underpin metabolic and cardiovascular diseases
    Peter D. Gluckman
    Mark A. Hanson
    Tatjana Buklijas
    Felicia M. Low
    Alan S. Beedle
    Nature Reviews Endocrinology, 2009, 5 : 401 - 408